These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9950291)

  • 1. Use of truncated areas to measure extent of drug absorption in bioequivalence studies: effects of drug absorption rate and elimination rate variability on this metric.
    Kharidia J; Jackson AJ; Ouderkirk LA
    Pharm Res; 1999 Jan; 16(1):130-4. PubMed ID: 9950291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUC0-INF).
    Martinez MN; Jackson AJ
    Pharm Res; 1991 Apr; 8(4):512-7. PubMed ID: 1871049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax.
    el-Tahtawy AA; Tozer TN; Harrison F; Lesko L; Williams R
    Pharm Res; 1998 Jan; 15(1):98-104. PubMed ID: 9487554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of truncated areas in the assessment of bioequivalence of immediate release formulations of drugs with long half-lives and of Cmax with different dissolution rates.
    Sathe P; Venitz J; Lesko L
    Pharm Res; 1999 Jun; 16(6):939-43. PubMed ID: 10397617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First measured plasma concentration value as C(max); impact on the C(max) confidence interval in bioequivalence studies.
    Jackson A; Conner D; Miller R
    Biopharm Drug Dispos; 2000 May; 21(4):139-46. PubMed ID: 11180192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An area correction method to reduce intrasubject variability in bioequivalence studies.
    Abdallah HY
    J Pharm Pharm Sci; 1998; 1(2):60-5. PubMed ID: 10945919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bioequivalence of highly variable drugs using Monte Carlo simulations. I. Estimation of rate of absorption for single and multiple dose trials using Cmax.
    el-Tahtawy AA; Jackson AJ; Ludden TM
    Pharm Res; 1995 Nov; 12(11):1634-41. PubMed ID: 8592662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of length of sampling schedule and washout interval on magnitude of drug carryover from period 1 to period 2 in two-period, two-treatment bioequivalence studies and its attendant effects on determination of bioequivalence.
    Dhariwal K; Jackson A
    Biopharm Drug Dispos; 2003 Jul; 24(5):219-28. PubMed ID: 12784322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of metabolites in bioequivalency assessment. III. Highly variable drugs with linear kinetics and first-pass effect.
    Jackson AJ
    Pharm Res; 2000 Nov; 17(11):1432-6. PubMed ID: 11205739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.
    Hammami MM; De Padua SJS; Hussein R; Al Gaai E; Khodr NA; Al-Swayeh R; Alvi SN; Binhashim N
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):78. PubMed ID: 29216899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence: performance of several measures of extent of absorption.
    Bois FY; Tozer TN; Hauck WW; Chen ML; Patnaik R; Williams RL
    Pharm Res; 1994 May; 11(5):715-22. PubMed ID: 8058642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncated area under the curve as a measure of relative extent of bioavailability: evaluation using experimental data and Monte Carlo simulations.
    Gaudreault J; Potvin D; Lavigne J; Lalonde RL
    Pharm Res; 1998 Oct; 15(10):1621-9. PubMed ID: 9794507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of single and multiple dose pharmacokinetics using clinical bioequivalence data and Monte Carlo simulations.
    el-Tahtawy AA; Jackson AJ; Ludden TM
    Pharm Res; 1994 Sep; 11(9):1330-6. PubMed ID: 7816765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F
    Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers.
    Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Santoso ID; Arland JA; Setiawati A; Lian LY
    Arzneimittelforschung; 2011; 61(4):234-8. PubMed ID: 21650082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model.
    Walker SE; Friesen MH
    J Pharm Pharm Sci; 1999; 2(1):15-22. PubMed ID: 10951658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioequivalence of highly variable drugs and drug products.
    Midha KK; Rawson MJ; Hubbard JW
    Int J Clin Pharmacol Ther; 2005 Oct; 43(10):485-98. PubMed ID: 16240706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system.
    Idkaidek N; Arafat T
    Drug Res (Stuttg); 2014 Oct; 64(10):559-62. PubMed ID: 24452519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.